A subscale commodity dye maker now pivoting into copper smelting with litigation proceeds

• Dyes & Intermediates (₹740 Cr). Reactive dyes, vinyl sulphone, H-acid across 5 Gujarat plants — EBITDA-negative for 3 straight years, running at 42% utilisation.
• DyStar stake (divested Dec 2025). 37.57% of the world's largest dye maker fed ₹373 Cr of associate profit in FY25; sold en bloc to Longsheng for US$689M after an 11-year Singapore suit.
• Indo Asia Copper (greenfield). Planned ₹13,300 Cr, 5 lakh TPA copper smelter plus 16.5 lakh TPA fertilizer complex at Jafrabad — construction started Oct 2025, Phase 1 targeted Apr 2027.

Three years of operating losses masked by a one-time ₹5,854 Cr DyStar gain

Revenue halved from ₹1,497 Cr (FY22) to ₹740 Cr (FY25) as Chinese dumping intensified. Other income has exceeded operating income in 7 of 9 years — this is an investment holding company with a loss-making plant attached.

C+ governance — promoters bought in at ₹369, but the board has no copper expertise

• Founder control. Chairman & MD Manish Kiri ran the 11-year DyStar suit that recovered ₹5,854 Cr; pay is a modest ₹1.5 Cr/yr with alignment via equity, not cash.
• Skin in the game. Kiri family invested ₹492 Cr at ₹369/share via warrants (now underwater vs ₹401 CMP); promoter stake rose from 26.7% to 41.71% as of April 2026.
• Capital allocation red flag. Zero dividend on a ₹5,854 Cr inflow; under 10% of proceeds may be considered for a special dividend. Board has no mining, smelting or project-finance background.
• Institutional exit. FIIs cut holding from 46.8% to 18.3% over 24 months; President of Operations Raja Mohaniya resigned Feb 9, 2026 mid-pivot.

A decade of litigation paralysis ends — replaced by a bet-the-company copper pivot

2015–2025: Litigation paralysis. After co-acquiring DyStar in 2010 with Longsheng, Kiri filed a minority oppression suit in Singapore in 2015. For a decade the case consumed management bandwidth, legal bills ran ₹30–50 Cr/year, growth capex froze, and standalone EBITDA turned negative in FY23. DyStar profit share kept reported net income positive the entire time — the dyes business was a commodity plant masquerading as a growth story.

2025–2026: Windfall & pivot. On Dec 30, 2025 Kiri received US$689M — beating the US$603.8M court award. Within weeks, management committed 90%+ of proceeds to a ₹13,300 Cr copper+fertilizer complex at Jafrabad, 5× the market cap, in an industry where Adani (5 lakh TPA operational) and Hindalco (US$10B plan) are already entrenched. Guidance has missed by 6 months on DyStar, multiple years on capacity utilisation.

DyStar cash lands, the copper bet begins — and institutions quietly walk away

• DyStar cash received. US$689.03M (₹5,862 Cr) hit the balance sheet Dec 30, 2025; Claronex's US$130M judgment-funding loan at ~15% was fully repaid Feb 13, 2026.
• Copper competition intensifies. Adani Kutch (5 lakh TPA, ramping to 10) is live; Hindalco announced a US$10B Dahej expansion in Aug 2025. Kiri's Phase 1 starts Apr 2027 — entering as China added 16M tonnes of smelting capacity in 2025.
• Makilala upstream talks. Q3 FY26 call disclosed discussions with Celsius Resources (ASX: CLA) and Philippines sovereign fund Maharlika for a 20–40% stake in Makilala Mining — first concrete move toward concentrate security.

Three risks that could each reprice the stock 30–50%

• Copper execution. ₹13,300 Cr project (5.6× market cap) in an industry Kiri has never operated in; only 50% of concentrate feedstock contracted, technology partner still unnamed, cost already crept from ₹10,661 Cr to ₹13,300 Cr.
• Capital misallocation. 90%+ of DyStar proceeds committed before shareholder review; project debt of ~₹8,500 Cr at the IACL subsidiary will balloon consolidated leverage from 0.37× to multiples of equity.
• Dye core in structural decline. −10.7% five-year revenue CAGR, 42–48% utilisation, material margin collapsed from 35.4% to 20.8% YoY. Without DyStar ballast, the next downturn is uncushioned.